Atlas Trials

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Clinical trial NCT00003670 · COMPLETED

Trial details

NCT number
NCT00003670
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian CancerPrimary Peritoneal Cavity Cancer
Start date
1998-10-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.